CN Stock MarketDetailed Quotes

301370 GKHT Medical Technology

Watchlist
  • 10.72
  • -0.18-1.65%
Market Closed Jul 12 15:00 CST
5.04BMarket Cap32.48P/E (TTM)

GKHT Medical Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
(Q6)Jun 30, 2021
Assets
Current assets
Money funds
36.32%788.14M
-18.73%507.85M
--625.2M
-12.84%510.44M
--578.14M
76.48%624.9M
54.80%585.63M
71.85%354.08M
--274.47M
6.80%378.31M
Notes receivable and accounts receivable
-17.01%1.89B
-8.85%2B
--2.35B
-5.21%2.32B
--2.27B
-5.64%2.19B
-1.24%2.44B
-4.64%2.32B
----
38.47%2.47B
-Notes receivable
82.66%173.86M
130.03%207.78M
--215.68M
-6.88%117.06M
--95.18M
3.10%90.33M
107.24%125.71M
154.95%87.61M
--56.53M
110.33%60.66M
-Accounts receivable
-21.36%1.71B
-14.81%1.79B
--2.13B
-5.12%2.2B
--2.18B
-5.98%2.1B
-3.97%2.32B
-6.92%2.24B
----
37.29%2.41B
Other receivables (including interest and dividends)
15.95%159.16M
19.30%165.17M
--129.82M
-3.96%122.43M
--137.27M
8.19%138.46M
-7.30%127.47M
4.79%127.98M
----
-16.23%137.51M
-Other receivable
----
----
----
-3.96%122.43M
--137.27M
8.19%138.46M
-7.30%127.47M
4.79%127.98M
----
-16.23%137.51M
Advance payment
30.25%592.04M
17.40%550.47M
--501.77M
84.13%495.12M
--454.54M
59.69%468.88M
2.32%268.89M
14.46%293.62M
----
-0.06%262.8M
Inventories
-8.98%2.67B
-10.84%2.66B
--2.86B
1.62%2.92B
--2.94B
1.42%2.98B
2.53%2.88B
3.74%2.94B
----
0.56%2.81B
Receivable financing
-44.19%24.99M
163.40%95.87M
--42.21M
69.14%52.89M
--44.79M
28.88%36.4M
147.97%31.27M
48.30%28.24M
--28.59M
-25.20%12.61M
Other current assets
-39.86%156.02M
22.47%279.26M
--271.13M
5.14%255.6M
--259.44M
-21.84%228.01M
-4.34%243.09M
25.98%291.73M
----
4.96%254.11M
Total current assets
-6.05%6.28B
-6.22%6.25B
--6.77B
1.51%6.68B
--6.69B
4.90%6.67B
3.97%6.58B
4.15%6.36B
----
12.60%6.33B
Non Current assets
Fixed assets
----
----
----
-12.89%33.77M
--36.26M
-8.88%37.68M
-7.64%38.76M
7.61%41.35M
----
49.26%41.97M
Constru in process
----
----
----
117.02%394.78M
--388.27M
286.88%364.95M
1,224.38%181.91M
--94.33M
--57.08M
--13.74M
Intangible assets
6.93%107.8M
12.29%114.48M
--111.81M
14.06%110.89M
--100.81M
7.95%101.95M
0.82%97.22M
-1.14%94.44M
----
4.34%96.43M
Long deferred expense
-23.04%3.71M
-38.99%3.42M
--3.48M
-36.99%4.05M
--4.82M
-35.43%5.6M
-44.10%6.43M
-47.84%8.68M
--9.5M
-35.30%11.5M
Deferred tax assets
1.16%60.85M
21.68%49.17M
--66.77M
49.80%65.16M
--60.15M
13.92%40.41M
46.33%43.5M
33.67%35.47M
----
67.03%29.73M
Usufruct assets
8.21%55.97M
-26.97%45.72M
--43.44M
-28.10%48.44M
--51.72M
-24.70%62.61M
14.89%67.37M
29.62%83.14M
--53.77M
--58.64M
Other non current assets
16.79%25.09M
-42.14%13.9M
--33.13M
-44.01%15.45M
--21.49M
-15.33%24.03M
41.23%27.59M
33.27%28.38M
----
22.00%19.54M
Total non current assets
21.54%806.46M
22.80%782.52M
--685.4M
45.33%672.54M
--663.52M
65.17%637.23M
70.44%462.78M
46.93%385.79M
----
57.76%271.53M
Total assets
-3.56%7.09B
-3.69%7.04B
--7.46B
4.39%7.35B
--7.35B
8.35%7.31B
6.71%7.04B
5.91%6.74B
--6.6B
13.94%6.6B
Liabilities
Current liabilities
Short term loan
-43.98%1.22B
-55.71%1.09B
--1.31B
-17.44%1.86B
--2.17B
2.91%2.45B
-0.02%2.25B
7.92%2.38B
----
5.42%2.26B
Notes payable and accounts payable
-14.49%2.33B
0.05%2.49B
--2.73B
11.82%2.9B
--2.73B
3.84%2.49B
4.74%2.59B
0.44%2.4B
----
20.70%2.47B
-Notes payable
22.55%106.71M
57.91%115.13M
--97.86M
165.57%76.77M
--87.07M
143.02%72.91M
-59.40%28.91M
-55.66%30M
----
-53.83%71.21M
-Accounts payable
-15.71%2.22B
-1.70%2.37B
--2.63B
10.09%2.82B
--2.64B
2.07%2.41B
6.64%2.56B
2.08%2.37B
----
26.77%2.4B
Contract liabilities
-13.49%155.66M
-9.27%148.31M
--122.91M
33.65%198.53M
--179.93M
109.09%163.46M
32.98%148.55M
17.83%78.18M
----
16.21%111.71M
Salaries payable
-25.93%13.71M
-4.14%23.61M
--24.22M
21.96%24.57M
--18.51M
5.97%24.63M
11.62%20.15M
12.48%23.24M
----
7.54%18.05M
Taxs payable
7.33%36.03M
49.93%38.49M
--36.72M
21.43%31.42M
--33.57M
-48.98%25.67M
-24.03%25.88M
45.83%50.31M
----
39.06%34.06M
Other payable (including interest and dividends)
39.96%453.26M
27.30%390.44M
--398.64M
21.44%369.74M
--323.84M
18.76%306.72M
12.48%304.47M
-6.89%258.26M
----
-4.73%270.68M
-Dividend payable
----
----
----
----
----
----
--181.81K
--181.81K
----
----
-Other payable
----
----
----
21.51%369.74M
--323.84M
18.85%306.72M
12.41%304.29M
-6.95%258.08M
----
-4.73%270.68M
Non current liabilities due within one year
80.31%138.43M
67.59%138.42M
--77.08M
25.84%78.9M
--76.77M
90.12%82.59M
110.94%62.7M
134.11%43.44M
--29.4M
--29.72M
Other current liabilities
-13.49%20.24M
-9.27%19.28M
--15.98M
33.65%25.81M
--23.39M
109.09%21.25M
32.98%19.31M
17.83%10.16M
----
16.21%14.52M
Total current liabilities
-21.41%4.37B
-22.12%4.33B
--4.71B
1.12%5.49B
--5.55B
6.15%5.56B
4.21%5.42B
4.44%5.24B
----
12.65%5.21B
Current liabilities
Long term loan
-24.47%136.53M
-15.67%136.53M
--225.46M
245.40%205.36M
--180.76M
--161.91M
--59.46M
----
----
----
Deferred tax liabilities
-73.84%3.92M
58.86%1.89M
--12.47M
--13.81M
--14.97M
--1.19M
----
----
----
----
Long term deferred income
-12.25%4.84M
-15.24%5.07M
--4.56M
-27.42%5.03M
--5.51M
-24.11%5.99M
3.26%6.94M
3.01%7.89M
----
90.50%6.72M
Lease liabilities
73.52%18.05M
-43.73%9.1M
--9.25M
-40.75%10.62M
--10.4M
-45.18%16.16M
-14.66%17.93M
-35.31%29.49M
--17.83M
--21.01M
Total non current liabilities
-22.83%163.33M
-17.63%152.59M
--251.73M
178.50%234.84M
--211.65M
395.65%185.25M
204.14%84.32M
-33.45%37.37M
----
686.26%27.73M
Total liabilities
-21.46%4.53B
-21.97%4.49B
--4.96B
3.83%5.72B
--5.77B
8.90%5.75B
5.26%5.51B
4.02%5.28B
--5.21B
13.16%5.23B
Shareholders equity
Paid-in capital
17.65%470.6M
17.65%470.6M
--470.6M
0.00%400M
--400M
0.00%400M
0.00%400M
0.00%400M
----
0.00%400M
Capital reserve funds
211.59%1.14B
211.58%1.14B
--1.14B
-0.16%365.04M
--365.04M
-0.15%365.06M
0.09%365.61M
0.09%365.61M
----
0.00%365.27M
Surplus reserve funds
20.23%77.45M
20.23%77.45M
--64.42M
23.44%64.42M
--64.42M
23.44%64.42M
21.52%52.18M
21.52%52.18M
----
41.80%42.94M
Retained profit
21.82%793.37M
22.54%765.76M
--715.93M
21.27%690.84M
--651.25M
21.05%624.92M
32.34%569.66M
37.93%516.26M
----
54.99%430.44M
Less:Treasury stock
--11.03M
----
----
----
----
----
----
----
----
----
Shareholders equity without minority interests
66.67%2.47B
68.54%2.45B
--2.39B
9.57%1.52B
--1.48B
9.02%1.45B
12.01%1.39B
12.82%1.33B
--1.27B
15.41%1.24B
Minority interests
-10.94%92.77M
-3.27%99.28M
--109.7M
-24.48%107.93M
--104.16M
-20.89%102.64M
14.61%142.9M
19.11%129.75M
----
35.85%124.69M
Total shareholder equity
61.57%2.56B
63.81%2.55B
--2.5B
6.39%1.63B
--1.58B
6.37%1.56B
12.25%1.53B
13.35%1.46B
--1.39B
17.02%1.36B
Total liabilityies and equity
-3.56%7.09B
-3.69%7.04B
--7.46B
4.39%7.35B
--7.35B
8.35%7.31B
6.71%7.04B
5.91%6.74B
--6.6B
13.94%6.6B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
Unqualified opinion
--
--
Auditor
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
Grant Tung Certified Public Accountants (Special General Partnership)
--
--
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021(Q6)Jun 30, 2021
Assets
Current assets
Money funds 36.32%788.14M-18.73%507.85M--625.2M-12.84%510.44M--578.14M76.48%624.9M54.80%585.63M71.85%354.08M--274.47M6.80%378.31M
Notes receivable and accounts receivable -17.01%1.89B-8.85%2B--2.35B-5.21%2.32B--2.27B-5.64%2.19B-1.24%2.44B-4.64%2.32B----38.47%2.47B
-Notes receivable 82.66%173.86M130.03%207.78M--215.68M-6.88%117.06M--95.18M3.10%90.33M107.24%125.71M154.95%87.61M--56.53M110.33%60.66M
-Accounts receivable -21.36%1.71B-14.81%1.79B--2.13B-5.12%2.2B--2.18B-5.98%2.1B-3.97%2.32B-6.92%2.24B----37.29%2.41B
Other receivables (including interest and dividends) 15.95%159.16M19.30%165.17M--129.82M-3.96%122.43M--137.27M8.19%138.46M-7.30%127.47M4.79%127.98M-----16.23%137.51M
-Other receivable -------------3.96%122.43M--137.27M8.19%138.46M-7.30%127.47M4.79%127.98M-----16.23%137.51M
Advance payment 30.25%592.04M17.40%550.47M--501.77M84.13%495.12M--454.54M59.69%468.88M2.32%268.89M14.46%293.62M-----0.06%262.8M
Inventories -8.98%2.67B-10.84%2.66B--2.86B1.62%2.92B--2.94B1.42%2.98B2.53%2.88B3.74%2.94B----0.56%2.81B
Receivable financing -44.19%24.99M163.40%95.87M--42.21M69.14%52.89M--44.79M28.88%36.4M147.97%31.27M48.30%28.24M--28.59M-25.20%12.61M
Other current assets -39.86%156.02M22.47%279.26M--271.13M5.14%255.6M--259.44M-21.84%228.01M-4.34%243.09M25.98%291.73M----4.96%254.11M
Total current assets -6.05%6.28B-6.22%6.25B--6.77B1.51%6.68B--6.69B4.90%6.67B3.97%6.58B4.15%6.36B----12.60%6.33B
Non Current assets
Fixed assets -------------12.89%33.77M--36.26M-8.88%37.68M-7.64%38.76M7.61%41.35M----49.26%41.97M
Constru in process ------------117.02%394.78M--388.27M286.88%364.95M1,224.38%181.91M--94.33M--57.08M--13.74M
Intangible assets 6.93%107.8M12.29%114.48M--111.81M14.06%110.89M--100.81M7.95%101.95M0.82%97.22M-1.14%94.44M----4.34%96.43M
Long deferred expense -23.04%3.71M-38.99%3.42M--3.48M-36.99%4.05M--4.82M-35.43%5.6M-44.10%6.43M-47.84%8.68M--9.5M-35.30%11.5M
Deferred tax assets 1.16%60.85M21.68%49.17M--66.77M49.80%65.16M--60.15M13.92%40.41M46.33%43.5M33.67%35.47M----67.03%29.73M
Usufruct assets 8.21%55.97M-26.97%45.72M--43.44M-28.10%48.44M--51.72M-24.70%62.61M14.89%67.37M29.62%83.14M--53.77M--58.64M
Other non current assets 16.79%25.09M-42.14%13.9M--33.13M-44.01%15.45M--21.49M-15.33%24.03M41.23%27.59M33.27%28.38M----22.00%19.54M
Total non current assets 21.54%806.46M22.80%782.52M--685.4M45.33%672.54M--663.52M65.17%637.23M70.44%462.78M46.93%385.79M----57.76%271.53M
Total assets -3.56%7.09B-3.69%7.04B--7.46B4.39%7.35B--7.35B8.35%7.31B6.71%7.04B5.91%6.74B--6.6B13.94%6.6B
Liabilities
Current liabilities
Short term loan -43.98%1.22B-55.71%1.09B--1.31B-17.44%1.86B--2.17B2.91%2.45B-0.02%2.25B7.92%2.38B----5.42%2.26B
Notes payable and accounts payable -14.49%2.33B0.05%2.49B--2.73B11.82%2.9B--2.73B3.84%2.49B4.74%2.59B0.44%2.4B----20.70%2.47B
-Notes payable 22.55%106.71M57.91%115.13M--97.86M165.57%76.77M--87.07M143.02%72.91M-59.40%28.91M-55.66%30M-----53.83%71.21M
-Accounts payable -15.71%2.22B-1.70%2.37B--2.63B10.09%2.82B--2.64B2.07%2.41B6.64%2.56B2.08%2.37B----26.77%2.4B
Contract liabilities -13.49%155.66M-9.27%148.31M--122.91M33.65%198.53M--179.93M109.09%163.46M32.98%148.55M17.83%78.18M----16.21%111.71M
Salaries payable -25.93%13.71M-4.14%23.61M--24.22M21.96%24.57M--18.51M5.97%24.63M11.62%20.15M12.48%23.24M----7.54%18.05M
Taxs payable 7.33%36.03M49.93%38.49M--36.72M21.43%31.42M--33.57M-48.98%25.67M-24.03%25.88M45.83%50.31M----39.06%34.06M
Other payable (including interest and dividends) 39.96%453.26M27.30%390.44M--398.64M21.44%369.74M--323.84M18.76%306.72M12.48%304.47M-6.89%258.26M-----4.73%270.68M
-Dividend payable --------------------------181.81K--181.81K--------
-Other payable ------------21.51%369.74M--323.84M18.85%306.72M12.41%304.29M-6.95%258.08M-----4.73%270.68M
Non current liabilities due within one year 80.31%138.43M67.59%138.42M--77.08M25.84%78.9M--76.77M90.12%82.59M110.94%62.7M134.11%43.44M--29.4M--29.72M
Other current liabilities -13.49%20.24M-9.27%19.28M--15.98M33.65%25.81M--23.39M109.09%21.25M32.98%19.31M17.83%10.16M----16.21%14.52M
Total current liabilities -21.41%4.37B-22.12%4.33B--4.71B1.12%5.49B--5.55B6.15%5.56B4.21%5.42B4.44%5.24B----12.65%5.21B
Current liabilities
Long term loan -24.47%136.53M-15.67%136.53M--225.46M245.40%205.36M--180.76M--161.91M--59.46M------------
Deferred tax liabilities -73.84%3.92M58.86%1.89M--12.47M--13.81M--14.97M--1.19M----------------
Long term deferred income -12.25%4.84M-15.24%5.07M--4.56M-27.42%5.03M--5.51M-24.11%5.99M3.26%6.94M3.01%7.89M----90.50%6.72M
Lease liabilities 73.52%18.05M-43.73%9.1M--9.25M-40.75%10.62M--10.4M-45.18%16.16M-14.66%17.93M-35.31%29.49M--17.83M--21.01M
Total non current liabilities -22.83%163.33M-17.63%152.59M--251.73M178.50%234.84M--211.65M395.65%185.25M204.14%84.32M-33.45%37.37M----686.26%27.73M
Total liabilities -21.46%4.53B-21.97%4.49B--4.96B3.83%5.72B--5.77B8.90%5.75B5.26%5.51B4.02%5.28B--5.21B13.16%5.23B
Shareholders equity
Paid-in capital 17.65%470.6M17.65%470.6M--470.6M0.00%400M--400M0.00%400M0.00%400M0.00%400M----0.00%400M
Capital reserve funds 211.59%1.14B211.58%1.14B--1.14B-0.16%365.04M--365.04M-0.15%365.06M0.09%365.61M0.09%365.61M----0.00%365.27M
Surplus reserve funds 20.23%77.45M20.23%77.45M--64.42M23.44%64.42M--64.42M23.44%64.42M21.52%52.18M21.52%52.18M----41.80%42.94M
Retained profit 21.82%793.37M22.54%765.76M--715.93M21.27%690.84M--651.25M21.05%624.92M32.34%569.66M37.93%516.26M----54.99%430.44M
Less:Treasury stock --11.03M------------------------------------
Shareholders equity without minority interests 66.67%2.47B68.54%2.45B--2.39B9.57%1.52B--1.48B9.02%1.45B12.01%1.39B12.82%1.33B--1.27B15.41%1.24B
Minority interests -10.94%92.77M-3.27%99.28M--109.7M-24.48%107.93M--104.16M-20.89%102.64M14.61%142.9M19.11%129.75M----35.85%124.69M
Total shareholder equity 61.57%2.56B63.81%2.55B--2.5B6.39%1.63B--1.58B6.37%1.56B12.25%1.53B13.35%1.46B--1.39B17.02%1.36B
Total liabilityies and equity -3.56%7.09B-3.69%7.04B--7.46B4.39%7.35B--7.35B8.35%7.31B6.71%7.04B5.91%6.74B--6.6B13.94%6.6B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion--Unqualified opinion----
Auditor --Grant Tung Certified Public Accountants (Special General Partnership)------Grant Tung Certified Public Accountants (Special General Partnership)--Grant Tung Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg